熱門資訊> 正文

Pliant Therapeutics GAAP每股收益为-0.38美元在线

2026-03-12 04:36

Pliant Therapeutics(PLRX) 0
奧本海默控股(OPY) 0

Pliant Therapeutics press release (PLRX): Q4 GAAP EPS of -$0.38 in-line.
As of December 31, 2025, the Company had cash, cash equivalents and short-term investments of $192.4 million which the Company expects to be sufficient to fund operations into the second half of 2028.

More on Pliant Therapeutics

Pliant Therapeutics, Inc. (PLRX) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration
Seeking Alpha’s Quant Rating on Pliant Therapeutics
Historical earnings data for Pliant Therapeutics
Financial information for Pliant Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。